Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Birgitte Baldur-Felskov"'
Publikováno v:
Papillomavirus Research
Bollerup, S, Baldur-Felskov, B, Dehlendorff, C & Kjaer, S K 2017, ' Socioeconomic predictors of human papillomavirus vaccination in Danish men : A nationwide study ', Papillomavirus Research, vol. 3, pp. 18-23 . https://doi.org/10.1016/j.pvr.2016.11.004
Bollerup, S, Baldur-Felskov, B, Dehlendorff, C & Kjaer, S K 2017, ' Socioeconomic predictors of human papillomavirus vaccination in Danish men : A nationwide study ', Papillomavirus Research, vol. 3, pp. 18-23 . https://doi.org/10.1016/j.pvr.2016.11.004
Background The quadrivalent human papillomavirus vaccine was licensed in Denmark in 2006. Unlike women, men are not offered human papillomavirus vaccination free of charge but can have it at their own expense. We investigated human papillomavirus vac
Autor:
Julius Mwaiselage, Thomas Iftner, Vibeke Rasch, Susanne K. Kjaer, Birgitte Baldur-Felskov, Christian Munk, Myassa Kjaerem, Mette Tuxen Faber, Crispin Kahesa, Cecilie Dovey de la Cour
Publikováno v:
Baldur-Felskov, B, Mwaiselage, J, Faber, M T, Kjaerem, M, de la Cour, C D, Munk, C, Kahesa, C, Iftner, T, Rasch, V & Kjaer, S K 2019, ' Factors associated with a cervical high-grade lesion on cytology or a positive visual inspection with acetic acid among more than 3300 Tanzanian women ', Tropical Medicine & International Health, vol. 24, no. 2, pp. 229-237 . https://doi.org/10.1111/tmi.13184
OBJECTIVES: Cervical cancer screening by visual inspection with acetic acid (VIA) is a widely used alternative to cytology in developing countries. This study aimed to evaluate risk factors associated with a positive VIA test and with cervical high-g
Autor:
Signe Bollerup, Maria Blomberg, Susanne K. Kjaer, Louise Baandrup, Christian Dehlendorff, Birgitte Baldur-Felskov
Publikováno v:
Sexually Transmitted Diseases. 43:238-242
Background Denmark introduced the quadrivalent human papillomavirus vaccine into the vaccination program for 12- to 15-year-old girls in 2008 to 2009. In 2012, the program was supplemented with a catch-up program for women aged up to 27 years. We eva
Autor:
Eva Herweijer, Ingrid Uhnoo, Pär Sparén, Alexander Ploner, Christian Dehlendorff, Birgitte Baldur-Felskov, Lisen Arnheim-Dahlström, Susanne K. Kjaer
Publikováno v:
Vaccine. 36(43)
Background Based on immunogenicity studies, a 2 dose HPV vaccination-schedule was recently recommended for girls younger than 15 years. We aimed to investigate the effectiveness of quadrivalent HPV (qHPV) vaccination against CIN2 or worse (CIN2+), by
Autor:
Thor Schütt Svane Nielsen, Christian Dehlendorff, Christian Munk, Birgitte Baldur-Felskov, Jette Junge, Susanne K. Kjaer, Benny Kirschner
Publikováno v:
Cancer Causes & Control. 26:1105-1116
The incidence of cervical cancer, including squamous cell carcinoma (SCC), has been decreasing in several developed countries since the onset of organized screening programs; in some countries, however, the incidence of adenocarcinoma has increased a
Autor:
Marianne Steding-Jessen, Vanna Albieri, Trille Kristina Kjaer, Susanne K. Kjaer, Allan Jensen, C. Johansen, Susanne Oksbjerg Dalton, Birgitte Baldur-Felskov
Publikováno v:
Human reproduction (Oxford, England). 28(3)
Do women who don't succeed in giving birth after an infertility evaluation have a higher risk of psychiatric disorders compared with women who do?The results indicated that being unsuccessful in giving birth after an infertility evaluation could be a
Publikováno v:
Cancer causescontrol : CCC. 23(2)
To assess the trends in incidence of penile cancer during 1978-2008 and high-grade penile intraepithelial neoplasia (PIN2/3) during 1998-2008 in Denmark.Using two nationwide registries, we estimated age- and period-specific incidence rates. Log-linea
Publikováno v:
Cancer Causes & Control. 23:661-662
We appreciate the interest and comments of Dr. Frisch et al. on our paper about the incidence of penile cancer and high-grade penile intraepithelial neoplasia grades 2 and 3 (PIN 2/3) in Denmark. As they correctly pointed out, we conducted the study
Publikováno v:
JNCI Journal of the National Cancer Institute. 106:djt460-djt460
In clinical trials, vaccines against human papillomavirus (HPV) have been highly effective against HPV16- or HPV18-associated cervical lesions. The quadrivalent HPV vaccine was licensed in 2006 and subsequently implemented in the Danish vaccination p